Glial cell-specific regulation of the JC virus early promoter by histone deacetylase inhibitors

被引:15
|
作者
Kim, SY
Woo, MS
Kim, WK
Choi, EC
Henson, JW
Kim, HS
机构
[1] Ewha Womans Univ, Sch Med, Ewha Inst Neurosci, Coll Med,Dept Neurosci, Seoul 110783, South Korea
[2] Ewha Womans Univ, Coll Med, Ewha Inst Neurosci, Dept Pharmacol, Seoul, South Korea
[3] Seoul Natl Univ, Coll Pharm, Seoul, South Korea
[4] Harvard Univ, Sch Med, Mol Neurooncol Lab, Charlestown, MA 02129 USA
关键词
D O I
10.1128/JVI.77.6.3394-3401.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The human polyomavirus JC virus is the etiologic agent of the fatal disease demyelinating progressive multifocal leukoencephalopathy. Although multiple transcription factors have been shown to interact with the JC virus promoter and regulate transcriptional activity, their relevance to cell specificity remains elusive. To investigate whether chromatin structure controls glial cell-specific expression of JC virus early genes, glial and nonglial cells were transfected with a reporter plasmid containing the JC virus early promoter and then treated with the histone deacetylase (HDAC) inhibitors trichostatin A (TSA) and sodium butyrate. TSA and butyrate induced 20- to 30-fold activation of the JC virus promoter in nonglial cells, whereas less than 2-fold induction was observed in glial cells. These results indicate that the JC virus early promoter might be highly suppressed in nonglial cells by hypoacetylated chromatin and activated by hyperacetylation. In support of this, chromatin immunoprecipitation assays demonstrated acetylation of the JC virus promoter region in U87MG cells but no acetylation in HeLa cells. In addition, treatment of HeLa cells with TSA induced hyperacetylation of the JC virus promoter, whereas minimal induction was seen in U87MG cells. Deletional and site-directed mutational analyses revealed that the enhancer region and Sp1 binding site upstream of the TATA box were important for TSA-mediated activation. We confirmed TSA-mediated activation of the JC virus promoter in the context of natural chromatin structure in stable cell lines. Thus, it appears that chromatin structure may control JC virus transcription in a cell-specific manner.
引用
收藏
页码:3394 / 3401
页数:8
相关论文
共 50 条
  • [31] Histone deacetylase inhibition leads to neuroprotection through regulation on glial function
    Xuefei Wu
    Shao Li
    Qiong Wu
    Yan Peng
    Deqin Yu
    Hecheng Wang
    Dehua Chui
    Jie Zhao
    Molecular Neurodegeneration, 8 (Suppl 1)
  • [32] Hypoxia-Regulated Retinal Glial Cell-Specific Promoter for Potential Gene Therapy in Disease
    Prentice, Howard M.
    Biswal, Manas R.
    Dorey, C. Kathleen
    Blanks, Janet C.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (12) : 8562 - 8570
  • [33] Histone deacetylase (HDAC) inhibitors reduce the glial inflammatory response in vitro and in vivo
    Faraco, Giuseppe
    Pittelli, Maria
    Cavone, Leonardo
    Fossati, Silvia
    Porcu, Marco
    Mascagni, Paolo
    Fossati, Gianluca
    Moroni, Flavio
    Chiarugi, Alberto
    NEUROBIOLOGY OF DISEASE, 2009, 36 (02) : 269 - 279
  • [34] Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors
    Lapierre, Marion
    Linares, Aurelien
    Dalvai, Mathieu
    Duraffourd, Celine
    Bonnet, Sandrine
    Boulahtouf, Abdelhay
    Rodriguez, Carmen
    Jalaguier, Stephan
    Assou, Said
    Orsetti, Beatrice
    Balaguer, Patrick
    Maudelonde, Thierry
    Blache, Philippe
    Bystricky, Kerstin
    Boulle, Nathalie
    Cavailles, Vincent
    ONCOTARGET, 2016, 7 (15) : 19693 - 19708
  • [35] Roles of histone deacetylase inhibitors in the regulation of DNA methyltransferase 1
    Takashima, Asami
    Faller, Douglas V.
    CANCER RESEARCH, 2011, 71
  • [36] Enhancement of Vaccinia Virus Based Oncolysis with Histone Deacetylase Inhibitors
    MacTavish, Heather
    Diallo, Jean-Simon
    Huang, Baocheng
    Stanford, Marianne
    Le Boeuf, Fabrice
    De Silva, Naomi
    Cox, Julie
    Simmons, John Graydon
    Guimond, Tanya
    Falls, Theresa
    McCart, Andrea J.
    Atkins, Harry
    Breitbach, Caroline
    Kirn, David
    Thorne, Stephen
    Bell, John C.
    PLOS ONE, 2010, 5 (12):
  • [37] Isoform-specific histone deacetylase inhibitors: The next step?
    Balasubramanian, Sriram
    Verner, Erik
    Buggy, Joseph J.
    CANCER LETTERS, 2009, 280 (02) : 211 - 221
  • [38] Cell-specific histone modifications in atherosclerosis (Review)
    Jiang, Wanlin
    Agrawal, Devendra K.
    Boosani, Chandra S.
    MOLECULAR MEDICINE REPORTS, 2018, 18 (02) : 1215 - 1224
  • [39] Histone Deacetylase Inhibitors in Cell Pluripotency, Differentiation, and Reprogramming
    Kretsovali, Androniki
    Hadjimichael, Christiana
    Charmpilas, Nikolaos
    STEM CELLS INTERNATIONAL, 2012, 2012
  • [40] Histone deacetylase inhibitors repress chondrosarcoma cell proliferation
    Zhu, Jiaxue
    Gu, Jianhua
    Ma, Jie
    Xu, Zhixing
    Tao, Hairong
    JOURNAL OF BUON, 2015, 20 (01): : 269 - 274